medline.ch Onkologie Urologische Tumoren

	Bridging the implementation gap in hereditary cancer care for prostate cancer: a narrative review and Japanese environmental scan. Int J Clin Oncol Habano E, Sato Y, Ogawa M, Watanabe K, Akiyama N, Chang H, Shijiki E, Nagai S, Kunita A, Ueki A, Kage H, Oda K. PMID: 42842178 [PubMed - as supplied by publisher]
	Linear Accelerator-Based Stereotactic Body Radiotherapy of 36.25â€‰Gy in Five Fractions for Localised Prostate Cancer: A Retrospective Single-Institution Cohort Study. J Med Imaging Radiat Oncol Katano A, Yamashita H. PMID: 42841368 [PubMed - as supplied by publisher]
	Traditional Chinese medicine in non-muscle-invasive bladder cancer: a scoping review of syndrome characteristics and critical synthesis of pharmacological and mechanistic evidence. Front Pharmacol Zhang XZ, Xiang JA, Yang LC, Li YD, Zheng X, Qian J. PMID: 42840653 [PubMed]
	Impact of Cardio-cerebrovascular Diseases on Enzalutamide and Abiraterone Treatment in Castration-resistant Prostate Cancer. JMA J Kawai N, Izumi K, Yasui T, Shima T, Kato Y, Mita K, Okamura T, Inoue S, Tatarano S, Tanaka N, Kamiyama M, Chikazawa I, Hoshi S, Hashimoto K, Fukagai T, Shigehara K, Takahara S, Mizokami A. PMID: 42840419 [PubMed]
	Aromatic amine exposure and bladder cancer: a review of recent advances in epidemiology, pathogenesis, and prevention. Front Cell Dev Biol Li S, Zhang Y, Mao T, Wei J, Zhang W, Zhang J, Wei W. PMID: 42840084 [PubMed]
	Androgen receptor inhibitor double therapies in the management of metastatic castration-sensitive prostate cancer: a cost-effectiveness analysis. J Med Econ Padula WV, Cohen BG, Steel P, Appukkuttan S, Kalayeh B, Rettig M. PMID: 42839780 [PubMed - indexed for MEDLINE]
	Optimizing photon counting detector CT reconstructions for automatic vessel tracing in prostate artery embolization. J Appl Clin Med Phys Froelich T, Linch FB, Thompson SM, Jundt MC, Collins JD, Ferrero A, Favazza CP. PMID: 42839535 [PubMed - indexed for MEDLINE]
	Combined radiological approach for characterization of solid renal masses: a proposed strategy for integrating the RENAL nephrometry score into the clear cell likelihood score. BMC Med Imaging Hekimsoy , Tan AA, Sars, Güler E. PMID: 42839229 [PubMed - indexed for MEDLINE]
	Association of molecular subtypes based on GATA3, KRT5, and P16 expression with clinicopathological features and prognosis in upper tract urothelial carcinoma. World J Urol Yang J, Yu W, Zhang S, Chen Q. PMID: 42839075 [PubMed - indexed for MEDLINE]
	Re: Targeted Prostate Cancer Screening in BRCA1 or BRCA2 Pathogenic Germline Variant Carriers Detects Clinically Relevant Disease: Five-year Results of the IMPACT Study. Eur Urol Greco F. PMID: 42838800 [PubMed - as supplied by publisher]
	Major Adverse Cardiovascular Events in Men with High-risk Localized or Metastatic Prostate Cancer Starting Long-term Hormone Therapy in the STAMPEDE Trial. Eur Urol El-Taji O, Dutey-Magni P, Brown M, Murray M, Amos C, Gilbert D, Parmar M, Brown L, Sydes M, Attard G, James N, Clarke NW, Sachdeva A, STAMPEDE Collaborators. PMID: 42838799 [PubMed - as supplied by publisher]
	Adamantinoma-like Ewing sarcoma of the bladder. BMJ Case Rep Cronin C, Lokeshwar SD, Calagua C, Garman TS, Kates M, Aragon-Ching JB, Benyounes A, Smith AK. PMID: 42838705 [PubMed - indexed for MEDLINE]
	Superhydrophobic micro-structural substrate for renal cell carcinoma detection using LIBS-FTIR dual-spectra. Anal Chim Acta Chen W, Huang W, Li F, Guo L. PMID: 42838663 [PubMed - indexed for MEDLINE]
	Metastasis-directed radiotherapy (MDRT) for men with de novo, oligometastatic prostate cancer treated with long-term androgen deprivation therapy in the STAMPEDE trial (METANOVA): protocol for a multicentre, phase II randomised controlled trial in the USA. BMJ Open Lichtman-Mikol S, Lang JM, Nagar H, Zuhour R, Chaung KV, Zaorsky NG, Roy S, Mendiratta PM, Shoag JE, Janopaul-Naylor JR, Khani F, Schaeffer EM, Kyriakopoulos CE, Barata P, Brown JR, Garcia JA, Barbieri CE, Sun Y, Choyke PL, Spratt DE, Jia AY. PMID: 42838582 [PubMed - indexed for MEDLINE]
	The Impact of the Tumor Microenvironment on Immune Checkpoint Inhibitor Resistance in Prostate Cancer: Mechanistic Insights and Therapeutic Strategies. Crit Rev Oncol Hematol Zhou S, Bi Y, Xiong Z, Guo Y, Cui X, Zhang M. PMID: 42838467 [PubMed - as supplied by publisher]
	Impact on renal function, tumor volume, and complications of transarterial embolization for renal angiomyolipomas: An Evidence-Based systematic review and meta-analysis. J Vasc Interv Radiol Orra AF, Orra SH, Nabhan Martinez JV, Pinhata Otoch J, Shiomi da Cruz JA. PMID: 42838444 [PubMed - as supplied by publisher]
	SUMOylation and palmitoylation in metastatic prostate cancer: A compartment-based framework for nuclear and membrane adaptation. Biochem Biophys Res Commun Ji S, Li S, Wei Y, Zhu Q. PMID: 42837809 [PubMed - as supplied by publisher]
	Anticoagulation management and outcomes in cancer-associated gonadal and renal vein thrombosis: A multicenter retrospective cohort study. Thromb Res Butera E, Cavallaro C, D'Errico A, Talerico R, Mallick R, Kou R, Carrier M, Pola R, Wang TF. PMID: 42837788 [PubMed - as supplied by publisher]
	Effect of Marital Status on Longer Time from Diagnosis to External Beam Radiation Therapy in High-Risk Prostate Cancer Patients According to Race/Ethnicity. J Racial Ethn Health Disparities Quarta L, Polverino F, Petix M, Filzmayer M, Orlandi F, Goyal JA, Longo N, Ferro M, Chun FKH, Micali S, Shariat SF, Barletta F, Stabile A, Gandaglia G, Montorsi F, Saad F, Briganti A, Karakiewicz PI. PMID: 42837102 [PubMed - as supplied by publisher]
	Recent advances in discriminating prostate cancer from benign prostatic diseases in the pre-biopsy population. Med Oncol Nie Z, Zhu T, Chen Y, Zhang W, Wu L. PMID: 42837038 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 181992

Seite 1 von 9100

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung